Health
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients – WebWire
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS). The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus…
-
Business15 hours agoWarren Buffett says buy this index fund. It could turn $400 per month into $851,800 with help from Apple, Nvidia, and Tesla.
-
General11 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Noosa News10 hours agoSuspicious fire, Glenview – Sunshine Coast
-
Noosa News14 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns